EUVIMEDEUVIMED entdecken
Crossref

Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients

Yoshifumi Amari, Satoshi Morimoto, Takashi Teranishi, Yu Motoike, Takatomi Yurugi, Yasuo Oyama, Fumitaka Nakajima, Hitoshi Kobayashi

Clinical Nephrology · 2024

DOI: 10.5414/cn111179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nephrology, 2024. Verfasst von Yoshifumi Amari und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Renal Dialysis, COVID-19 Vaccines, COVID-19, Antibodies, Viral.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCOVID-19 VaccinesCOVID-19Antibodies, ViralSARS-CoV-2Antibodies, NeutralizingHumansMaleFemaleMiddle AgedAgedImmunoglobulin GSpike Glycoprotein, CoronavirusCase-Control StudiesVaccination

Substanzen

COVID-19 VaccinesAntibodies, ViralAntibodies, NeutralizingImmunoglobulin GSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Zitieren

APA

Amari, Y., Morimoto, S., Teranishi, T., Motoike, Y., Yurugi, T., Oyama, Y., Nakajima, F., & Kobayashi, H. (2024). Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients. Clinical Nephrology. https://doi.org/10.5414/cn111179

Vancouver

Amari Y, Morimoto S, Teranishi T, Motoike Y, Yurugi T, Oyama Y, et al. Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients. Clinical Nephrology. 2024. doi:10.5414/cn111179

BibTeX
@article{Amari2024,
  author = {Amari, Yoshifumi and Morimoto, Satoshi and Teranishi, Takashi and Motoike, Yu and Yurugi, Takatomi and Oyama, Yasuo and Nakajima, Fumitaka and Kobayashi, Hitoshi},
  title = {Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients},
  journal = {Clinical Nephrology},
  year = {2024},
  doi = {10.5414/cn111179}
}
Kostenlos starten →